Figures 3From: The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial designAmputation Free Survival over 1 year BMAC vs. Control (All study patients). The Kaplan-Meier curve demonstrates Amputation Free Survival (AFS) over 1 year in all study subjects with a negligible difference between BMAC and control.Back to article page